NCT00334399|CompletedPhase 3
Loading search results
Sponsor study identifier
interventional
N/A
1 country
13
Study Start
Not reported
Date not reportedPrimary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 26, 2006
Actual (reported)June 7, 2006
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Aichi, Japan
Chiba, Japan
Fukuoka, Japan
Gifu, Japan
Gunma, Japan
Hokkaido, Japan
Ibaraki, Japan
Kanagawa, Japan
Clinical Study Group, Clinical Development Dept.
Sanwa Kagaku Kenkyusho Co., Ltd.
First Submitted
May 26, 2006
First Posted
June 7, 2006
Last Updated
October 10, 2008
Record last verified: 2008-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
Contact the study team to confirm eligibility.
Kumamoto, Japan
Miyazaki, Japan
Osaka, Japan
Saitama, Japan
Tochigi, Japan